ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,071.17
0.53%
Dow Jones
44,882.13
0.38%
US Dollar vs MXN
20.67567
-0.02%
Brent Oil
76.005
-0.06%
Bitcoin
104,252.72
-0.47%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Ackermans and Van Haaren NV (ACKB) Cotización

Ackermans and Van Haaren NV

Ackermans and Van Haaren NV (ACKB)

EU
188.00
0.20
( 0.11% )
Actualizado: 02:23:31
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
188.00
Postura de Compra
187.80
Postura de Venta
188.00
Volume Operado de la Acción
1,645
187.80 Rango del Día 188.50
154.10 Rango de 52 semanas 198.30
Capitalización de Mercado [m]
6.297B
Precio Anterior
187.80
Precio de Apertura
188.10
Hora
1
@
188
Última hora de negociación
02:27:01
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
24,606
Acciones en circulación
33,497,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
15.76
Beneficio por acción (BPA)
11.92
turnover
4.99B
Beneficio neto
399.19M

Acerca de Ackermans and Van Haaren NV

Sector
Heavy Construction, Nec
Industria
Heavy Construction, Nec
Sitio web
www.avh.be
Sede
Antwerp, Antwerp, Bel
Fundado
1880
Ackermans and Van Haaren NV is listed in the Heavy Construction sector of the Euronext with ticker ACKB. The last closing price for Ackermans and Van Haaren... was 187.80 €. Over the last year, Ackermans and Van Haaren... shares have traded in a share price range of 154.10 € to 198.30 €.

Ackermans and Van Haaren... currently has 33,497,000 shares in issue. The market capitalisation of Ackermans and Van Haaren... is 6.29 € billion. Ackermans and Van Haaren... has a price to earnings ratio (PE ratio) of 15.76.

ACKB Últimas noticias

Más noticias

Ackermans & van Haaren Trading Update T3 2024 - AvH en bonne voie de réaliser un bénéfice bien supérieur à 400 millions d’euros.

Ackermans & van Haaren Trading Update T3 2024 - AvH en bonne voie de réaliser un bénéfice bien supérieur à 400 millions d’euros. Cher actionnaire, Monsieur, Madame, veuillez trouver ci-joint...

22 Noviembre 2024
UK Regulatory

Ackermans & van Haaren Trading Update Q3 2024 - AvH is on track towards a net profit well above 400 million euros

Ackermans & van Haaren Trading Update Q3 2024 - AvH is on track towards a net profit well above 400 million euros Dear shareholder, Dear Madam, Dear Sir, please find attached our press...

22 Noviembre 2024
UK Regulatory

Ackermans & van Haaren and the Delen family confirm their long-term partnership with updated shareholder arrangements in respect of Delen Private Bank and Bank J. Van Breda & Co

Ackermans & van Haaren and the Delen family confirm their long-term partnership with updated shareholder arrangements in respect of Delen Private Bank and Bank J. Van Breda & Co Dear...

21 Noviembre 2024
UK Regulatory

Ackermans & van Haaren et la famille Delen confirment leur partenariat à long terme en actualisant les conventions d'actionnaires concernant Delen Private Bank et Bank J.Van Breda & Co

Ackermans & van Haaren et la famille Delen confirment leur partenariat à long terme en actualisant les conventions d'actionnaires concernant Delen Private Bank et Bank J.Van Breda &...

21 Noviembre 2024
UK Regulatory

Ackermans & van Haaren investit 5 millions d’euros supplémentaires dans Biotalys

Ackermans & van Haaren investit 5 millions d’euros supplémentaires dans Biotalys Cher actionnaire, Monsieur, Madame, veuillez trouver ci-joint notre communiqué. Meilleures salutations...

14 Octubre 2024
UK Regulatory

Ackermans & van Haaren invests an additional 5 million euros in Biotalys

Ackermans & van Haaren invests an additional 5 million euros in Biotalys Dear shareholder, Dear Madam, Dear Sir, please find attached our press release. Best regards Ackermans & van Haaren...

14 Octubre 2024
UK Regulatory

Ackermans & van Haaren: Outstanding results in core participations result in a strong increase of AvH's net profit for 1H2024 to EUR 200 million (+17%)

Ackermans & van Haaren: Outstanding results in core participations result in a strong increase of AvH's net profit for 1H2024 to EUR 200 million (+17%) Dear shareholder, Dear Madam, Dear...

30 Agosto 2024
UK Regulatory

Ackermans & van Haaren : Des résultats exceptionnels dans les participations principales entraînent une forte augmentation du bénéfice net qui atteint € 200 millions (+17%)

Ackermans & van Haaren : Des résultats exceptionnels dans les participations principales entraînent une forte augmentation du bénéfice net qui atteint € 200 millions (+17%) Cher actionnaire...

30 Agosto 2024
UK Regulatory

Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company

Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company Dear shareholder, Dear Madam, Dear Sir, please...

26 Julio 2024
UK Regulatory

Ackermans & van Haaren mène une levée de fonds de série B de 60 millions d'euros pour Confo Therapeutics, une société biopharmaceutique belge

Ackermans & van Haaren mène une levée de fonds de série B de 60 millions d'euros pour Confo Therapeutics, une société biopharmaceutique belge Cher actionnaire, Monsieur, Madame, veuillez...

26 Julio 2024
UK Regulatory
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-6.9-3.54027706516194.9195.3182.325398184.89836995DE
4-5.9-3.04280556988193.9198.3182.320935190.55136228DE
121.30.696304231387186.7198.3178.924606187.88587389DE
2610.15.67734682406177.9198.3167.226135185.72222868DE
5232.520.9003215434155.5198.3154.126411173.95731447DE
15616.69.68494749125171.4198.3126.624623160.05006219DE
26042.929.5658166782145.1198.342.0425237148.92275765DE

ACKB - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Ackermans and Van Haaren...?
El precio actual de las acciones de Ackermans and Van Haaren... es 188.00 €
¿Cuántas acciones de Ackermans and Van Haaren... están en circulación?
Ackermans and Van Haaren... tiene 33,497,000 acciones en circulación
¿Cuál es la capitalización de mercado de Ackermans and Van Haaren...?
La capitalización de mercado de Ackermans and Van Haaren... es EUR 6.29B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Ackermans and Van Haaren...?
Ackermans and Van Haaren... ha negociado en un rango de 154.10 € a 198.30 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Ackermans and Van Haaren...?
El ratio precio/beneficio de Ackermans and Van Haaren... es 15.76
¿Cuál es el ratio de efectivo a ventas de Ackermans and Van Haaren...?
El ratio de efectivo a ventas de Ackermans and Van Haaren... es 1.26
¿Cuál es la moneda de reporte de Ackermans and Van Haaren...?
Ackermans and Van Haaren... presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Ackermans and Van Haaren...?
El último ingresos anual de Ackermans and Van Haaren... es EUR 4.99B
¿Cuál es el último beneficio anual de Ackermans and Van Haaren...?
El último beneficio anual de Ackermans and Van Haaren... es EUR 399.19M
¿Cuál es la dirección registrada de Ackermans and Van Haaren...?
La dirección registrada de Ackermans and Van Haaren... es BEGIJNENVEST 113, ANTWERP, ANTWERP, 2000
¿Cuál es la dirección del sitio web de Ackermans and Van Haaren...?
La dirección del sitio web de Ackermans and Van Haaren... es www.avh.be
¿En qué sector industrial opera Ackermans and Van Haaren...?
Ackermans and Van Haaren... opera en el sector HEAVY CONSTRUCTION, NEC

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
BALYOBalyo S.A.
0.368 €
(22.06%)
53.36k
ALBOOBOOSTHEAT
0.042 €
(20.00%)
108.04k
ALCHIAlchimie
0.449 €
(15.13%)
44.33k
TUVDSBio UV Group DS
0.01 €
(13.64%)
37.35k
ALSPTSpartoo
0.41 €
(10.22%)
29.16k
ALCARCarmat
0.767 €
(-27.78%)
1.02M
ATEMEAteme
4.00 €
(-20.32%)
19.84k
GUIGuillemot Corp
6.32 €
(-19.18%)
19.7k
AELISAelis Farma SA
3.12 €
(-17.02%)
14.55k
ALENTEntreparticuliersCom
0.506 €
(-8.99%)
4k
ATOAtos SE
0.0022 €
(0.00%)
342.96M
ALCYBCybergun
0.0001 €
(0.00%)
20.11M
BCPBanco Comercial Portugues SA
0.5026 €
(-0.51%)
3.87M
ALHPIHopium SA
0.003 €
(0.00%)
1.22M
ALCARCarmat
0.767 €
(-27.78%)
1.02M

Discusión

Ver feed completo
diamondguru-one diamondguru-one 5 minutos hace
P' = $10,000 Series OO
U's = 130 bil ÷ 1.2 bil = 108 per share in Series A
Sure wish they would tell us so we would not have to guess hmmmmmmmmmmm

WOW//////////////LOOKS LIKE A 1 for 1 COOP SHARES ??? $108.00 ???
COOP
IceCold8 IceCold8 17 minutos hace
https://x.com/kaboomracks/status/1885239669572477367 still waiting for them to address shareholder concerns.....
CGAC
wimike wimike 22 minutos hace
Can anyone please tell me what date we can expect a decision from the UK? I have to get a grip on what I need to sell for my upcoming RMDs due by 4/1 and then again by 12/31 (the latest possible dates I have stretched it to).

Hope it is okay to share this cancer story with a happy e
NWBO
Seminole Red Seminole Red 26 minutos hace
about the same....174 out of 199
manibiotech manibiotech 27 minutos hace
You both are paid pumpers 
NWBO
martyDg martyDg 31 minutos hace
you're a pos!
NWBO
trunkmonk trunkmonk 37 minutos hace
silver is the most undervalued commodity since 1980, maybe one of the most undervalued investments since 1999. over 300 paper contracts to an oz, its absolutely insane. when will that bubble burst i do not know
GOLD
LVerstee LVerstee 40 minutos hace
@MrSteven Since I’ve been getting multiple inquiries about the 30th and your a active Indian staff member, I think it’s best if you could confirm or deny whether the staff meeting has taken place.
ITUP
SkeBallLarry SkeBallLarry 46 minutos hace
" I (think) this is it >>

For a fuller picture, watch it on Youtube >

https://www.bing.com/videos/riverview/relatedvideo?q=Tulsi+Gabbard+hearings+on+cspan&mid=3FF8ECBD3169D0AF8C4E3FF8ECBD3169D0AF8C4E&FORM=VIRE
LVerstee LVerstee 47 minutos hace
Ask your colleagues. It was Indian staff meeting only. So why ask me?
ITUP
LuckyPanda LuckyPanda 48 minutos hace
What is the next date for potential closure of the receivership? Are there any potential dates we should be looking for next? Why cant this receivership close already?!?

Going onto 17 years! What is the longest FDIC has taken to close out a receivership? Are we the longest now?
COOP
green maschine green maschine 51 minutos hace
Time to be careful flipping. This could take off at anytime.
TNXP
eagle8 eagle8 52 minutos hace
@d_stock07734

·Merck ran a mRNA trial on three tough targets: non-small-cell lung cancer, pancreatic cancer, and colorectal cancer. The trial results were posted two days ago.
https://clinicaltrials.gov/study/NCT03948763
2h

Seventy patients were enrolled.
NWBO
sentiment_stocks sentiment_stocks 57 minutos hace
I prefer two spaces after a period… not bc I’m a boomer (although I am), but because I think it makes the text easier and more inviting to read. One space runs the individual sentences too close together, IMO. :)
NWBO
kazzy kazzy 59 minutos hace
United States LNG Export Terminals Approved, Not Yet Built

There is only line item (MC1) under MARAD/USCG.

https://www.ferc.gov/media/us-lng-export-terminals-existing-approved-not-yet-built-and-proposed

As of January 28, 2025
Updated to reflect cha
TGLO
green maschine green maschine 1 hora hace
No, you go figure what the truth is. Just ask ChatGPT or MSFT Copilot, or some other Ai program to get some real answers to your misled beliefs. Dude you are waaay off base with your ideas.
TNXP
Jbone22 Jbone22 1 hora hace
I used to think it wasn't bad that I had around a .06-.07 average. Now I feel it's gonna take a huge pump to get to .01 
OWCP
236T568 236T568 1 hora hace
Yet another one 

https://x.com/acnewsitics/status/1884957033197097340?s=19
Menace212 Menace212 1 hora hace
What makes it even more incredible enticing is if we get even 1 fda approval we will go straight towards 50 cents and above if the cards are played correctly Rspi can become a impactful participant if not a mougel in the pharmaceutical sector considering how we have multiple compounds that have been
RSPI
TradingCharts TradingCharts 2 horas hace
Amprius SiCore: The Battery That Will Revolutionize EVs and Drones
[yt]yM4QkRee3cY[/yt]
AMPX
gbb777 gbb777 2 horas hace
https://news.bloomberglaw.com/tech-and-telecom-law/us-armys-development-of-microsoft-goggles-wins-nominees-praise

President Donald Trump’s nominee for Army secretary praised the service for a strategy that may lead to the purchase of thousands of high-tech goggles developed by Microso
VTSI
price_and_volume price_and_volume 2 horas hace
You wouldnt be underwater if you did.
style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 20.295px" Nobody reads your BS  style="font-size: 1em"You apparently have no idea how to discern truth from fiction, which is why
ENZC
DKLN DKLN 2 horas hace
Shareholders have never been taken care with zippo substantive accomplishments in 6+ years. Also, potential investors couldn't care less about pushers saying, numerous times, they believe when pushers refuse to buy this near triple zero stock.

MCIC - To Uranus
MCIC
DewDiligence DewDiligence 2 horas hace
MAZE IPOs 10.1* shares @$16.00:

https://www.globenewswire.com/news-release/2025/01/31/3018524/0/en/Maze-Therapeutics-Announces-Pricing-of-Upsized-Initial-Public-Offering.html Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to dev

Su Consulta Reciente

EU
ACKB
Ackermans and Van Haaren...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios